Condition
Posterior Urethral Valve
Total Trials
6
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
Early P 1 (1)
P 3 (1)
Trial Status
Recruiting3
Completed1
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06439862Recruiting
Study of the Quality of Life in School Aged-children With Posterior Urethral Valves
NCT07668232Not ApplicableCompletedPrimary
Efficacy and Safety of Mirabegron Versus Oxybutynin After Posterior Urethral Valve Ablation
NCT04626167Early Phase 1Recruiting
Concomitant Renal and Urinary Bladder Allograft Transplantation
NCT06867263Not Yet RecruitingPrimary
Outcomes of Posterior Urethral Valve Fulguration
NCT06737016Phase 3RecruitingPrimary
Efficacy and Safety of Tamsulosin for Children with Posterior Urethral Valve.
NCT05168358Not ApplicableUnknownPrimary
Overnight Bladder Drainage and Posterior Urethral Valve Sequelae
Showing all 6 trials